Skip to main content
OpenTrials

Clinical trial condition

Neisseriaceae Infections

Explore clinical trials studying Neisseriaceae Infections. Study availability and eligibility vary by location and protocol.

400 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Neisseriaceae Infections trial results

Completed

Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection

NCT04350138

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Communicable Diseases, +9 more
Locations
  • University of Alabama at Birmingham School of Medicine - Infectious Disease Birmingham, Alabama, United States
  • UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States
  • SFDPH Bridge HIV Center San Francisco, California, United States
  • Emory University School of Medicine - The Ponce de Leon Center Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

NCT06369220

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Chlamydia Trachomatis Infection, +14 more
Locations
  • San Francisco City Clinic San Francisco, California, United States
  • Planned Parenthood of Northern, Central, and Southern New Jersey, Inc. Hamilton Square, New Jersey, United States
  • Planned Parenthood of Northern, Central and Southern New Jersey Perth Amboy, New Jersey, United States
  • Baylor Scott & White Health - Kileen Killeen, Texas, United States
View Trial Details
Completed

A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants

NCT05082285

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Santo Domingo Este, Dominican Republic
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
View all 33 locations
View Trial Details

Related conditions